TDOC logo

Teladoc Health, Inc. Stock Price

NYSE:TDOC Community·US$1.6b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 81 Fair Values set on narratives written by author

TDOC Share Price Performance

US$9.01
0.37 (4.28%)
24.9% undervalued intrinsic discount
US$12.00
Fair Value
US$9.01
0.37 (4.28%)
24.9% undervalued intrinsic discount
US$12.00
Fair Value
Price US$9.01
AnalystHighTarget US$12.00
AnalystConsensusTarget US$9.13
AnalystLowTarget US$7.00

TDOC Community Narratives

AnalystHighTarget·Updated
Fair Value US$12 24.9% undervalued intrinsic discount

Accelerated Digitalization And Aging Trends Will Redefine Virtual Care

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AnalystConsensusTarget·Updated
Fair Value US$9.13 1.3% undervalued intrinsic discount

Digital Chronic Care And International Expansion Will Unlock Future Markets

0users have liked this narrative
0users have commented on this narrative
39users have followed this narrative
AnalystLowTarget·Updated
Fair Value US$7 28.7% overvalued intrinsic discount

Rising Global Regulations And Healthcare Pressures Will Lower Valuation

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative

Recent TDOC News & Updates

Teladoc Health: The Upside Is Tantalizing, But The Risks Are Too High

Sep 03

Teladoc Health, Inc. (NYSE:TDOC) Shares Could Be 49% Below Their Intrinsic Value Estimate

Aug 27
Teladoc Health, Inc. (NYSE:TDOC) Shares Could Be 49% Below Their Intrinsic Value Estimate

The Teladoc Health, Inc. (NYSE:TDOC) Second-Quarter Results Are Out And Analysts Have Published New Forecasts

Jul 31
The Teladoc Health, Inc. (NYSE:TDOC) Second-Quarter Results Are Out And Analysts Have Published New Forecasts

Teladoc Health, Inc.'s (NYSE:TDOC) Low P/S No Reason For Excitement

Jun 18
Teladoc Health, Inc.'s (NYSE:TDOC) Low P/S No Reason For Excitement

Teladoc Health, Inc. Key Details

US$2.5b

Revenue

US$756.0m

Cost of Revenue

US$1.8b

Gross Profit

US$2.0b

Other Expenses

-US$207.4m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
-1.17
Gross Margin
70.26%
Net Profit Margin
-8.16%
Debt/Equity Ratio
69.8%

Teladoc Health, Inc. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Flawless balance sheet and undervalued.

1 Risk
3 Rewards

About TDOC

Founded
2002
Employees
5060
CEO
Charles Divita
WebsiteView website
www.teladochealth.com

Teladoc Health, Inc. provides virtual healthcare services worldwide. It operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counselling and therapy services through website, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

U.S. Market Performance

  • 7 Days: 1.2%
  • 3 Months: 8.5%
  • 1 Year: 17.7%
  • Year to Date: 14.8%
The market is up 1.2% over the last week, with the Information Technology sector leading the way, up 2.4%. In the last year, the market has climbed 18%. As for the next few years, earnings are expected to grow by 15% per annum. Market details ›